Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adoptive immunotherapy in chimeras with donor lymphocytes.

Hans-Jochem Kolb1, Christoph Schmid, Xiao Chen

  • 1Department of Medicine III, Klinikum University of Munich-Grosshadern, and GSF-National Research Center for Environment and Health, Munich, Germany. kolb@med3.med.uni-muenchen.de

Acta Haematologica
|October 30, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Leukemic Blood Samples with Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Is Associated with Reduced Frequencies of Tolerogenic Dendritic Cells and Increased Cytotoxicity Against Autologous Blasts.

Biomedicines·2026
Same author

Modulation of Leukemic Blasts into Dendritic Cells (DC<sub>leu</sub>) and Their Role in Predicting Survival in Patients with AML and MDS.

Cancers·2026
Same author

Prophylactic Donor Lymphocyte Infusions in Pediatric Patients With High-Risk Hematological Malignancies.

European journal of haematology·2026
Same author

Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenib.

Haematologica·2026
Same author

Development of a Speech Intelligibility Test for Children in Swiss German Dialects.

Audiology research·2026
Same author

Class III Obesity as a Presenting Syndrome in Prolactinoma Patients: Insights Into Obesity and Metabolic Dysfunction in This Unique Group.

Clinical obesity·2026

Donor lymphocyte infusions can induce remissions in hematological malignancies by separating the graft-versus-leukemia effect from graft-versus-host disease. This approach shows promise for treating chronic myelogenous leukemia and other blood cancers.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Allogeneic stem cell transplantation is a standard treatment for hematological malignancies.
  • The graft-versus-leukemia (GVL) effect is crucial for long-term remission.
  • Separating GVL from graft-versus-host disease (GVHD) is a key challenge.

Purpose of the Study:

  • To evaluate the efficacy of donor lymphocyte infusions (DLIs) in treating hematological malignancies.
  • To explore methods for mitigating GVHD while preserving the GVL effect.
  • To assess DLI outcomes across various hematological cancers.

Main Methods:

  • Clinical studies involving DLIs in patients with relapsed hematological malignancies.
  • Strategies to modulate GVHD, including CD8+ T cell depletion and dose adjustments.

Related Experiment Videos

  • Combination therapies for relapsed acute myeloid leukemia (AML) and multiple myeloma (MMY).

    • Main Results:

    • Complete molecular remissions achieved in chronic myelogenous leukemia (CML) patients.
    • Successful responses observed in relapsed AML, myelodysplastic syndromes, and MMY.
    • GVHD occurred but was generally less severe than anticipated; myelosuppression noted in CML.

    Conclusions:

    • DLIs are effective in inducing durable remissions, particularly in CML.
    • Optimizing DLI protocols can reduce GVHD and improve outcomes in AML and MMY.
    • Further research is needed to overcome immune escape mechanisms and manage chronic GVHD.